Rare diseases
Investigational molecules
Locations
Back to Germany689 clinical trials in Bad Krozingen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Safety and Effectiveness of Inclisiran for Children Aged 6 to Under 12 with Familial Hypercholesterolemia
GermanyStudy on PRAX-628 for Adults with Focal Onset or Generalized Tonic-Clonic Seizures
GermanyStudy on Continuing Nivolumab and Ipilimumab Treatment vs. Observation in Patients with Stage IV Non-Small Cell Lung Cancer
FranceStudy of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer
GermanyStudy on Chemotherapy with Levoleucovorin, Capecitabine, and Folinic Acid for Patients Aged 70+ After Stage III Colon Cancer Surgery
FranceStudy on the Effects of Brepocitinib and Prednisone for Adults with Active Non-Infectious Uveitis
GermanyStudy of rituximab and belimumab combination compared to rituximab alone in adults with persistent or chronic immune thrombocytopenia (ITP)
FranceStudy of Atezolizumab, Carboplatin, and Paclitaxel for Elderly Patients with Advanced Non-Small Cell Lung Cancer
FranceStudy Comparing Lenalidomide, Daratumumab, and Dexamethasone for Frail Patients with Untreated Multiple Myeloma Not Eligible for High-Dose Therapy
BelgiumStudy Comparing Anitocabtagene Autoleucel with Standard Treatment for Patients with Relapsed or Refractory Multiple Myeloma
GermanyStudy of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups
GermanyStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on lipoprotein management and preventive therapies for cardiovascular disease, exploring new treatments to reduce major cardiovascular events in high-risk patients.
Advanced studies evaluating novel therapeutic approaches for better cardiovascular outcomes.
Clinical investigations into deep vein thrombosis treatments and prevention of systemic embolism, particularly in patients with atrial fibrillation.
Comprehensive research on blood clot prevention and treatment methodologies.
Studies addressing hypertension management and innovative treatments for acute coronary syndromes, including specialized interventions for heart attack prevention.
Evaluating cutting-edge therapies for various cardiac conditions.
Research focusing on peripheral arterial disease and advanced vascular interventions, including novel contrast medium strategies for better patient outcomes.
Developing safer and more effective vascular treatment approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
